Pharmaceuticals

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States

SUZHOU, China, and ROCKVILLE, Md., March 23, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the global Phase Ib/I...

2020-03-23 19:00 1654

Drug Registration Approval Granted for Sihuan Pharmaceutical's Pediatric Compound Amino Acid Injection (18AA-II)

HONG KONG, March 23, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that drug registration approval has been granted by the National Medical Products Administ...

2020-03-23 17:57 5077

European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius

GOTTINGEN, Germany, March 20, 2020 /PRNewswire/ -- On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction ...

2020-03-20 20:36 9466

Gencurix Releasing New Coronavirus Diagnostic Kit in the EU

SEOUL, South Korea, March 20, 2020 /PRNewswire/ -- A new diagnostic kit for the COVID-19, developed by Gencurix (KONEX 229000), will be available soon in Europe. GenePro COVID-19 Detection Test, developed in accordance to the WHO (World Health Organization) guidance for 'Laboratory testing for 2...

2020-03-20 16:23 2555

Prof. Oliver Sartor Joins Clarity's Advisory Board

SYDNEY, March 20, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that Prof.Oliver Sartor has joined Clarity's Advisory Board. Prof. Sartor is a medical oncologist and an internationally recognised exp...

2020-03-20 12:29 2370

Zhejiang Hisun Pharmaceutical Co. Ltd.: Favipiravir Works - Preliminary Clinical Studies Suggest Positive Effects on COVID-19 Patients

ZHEJIANG, China, March 20, 2020 /PRNewswire/ -- Since the outbreak of COVID-19, people around the globe have been eagerly awaiting a real breakthrough on its treatment. Fortunately, a silver lining seems finally to be showing up.  

2020-03-20 03:50 4204

ChemPartner Introduces New State-of-the-Art Global Operation Center in Shanghai

SHANGHAI, March 17, 2020 /PRNewswire/ -- Shanghai ChemPartner announced the opening of a new, state-of-the-art,24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park inShanghai, China. The building, operating as ChemPartner's new Global Operation Center, houses approximately 700 employees ...

2020-03-17 23:07 1897

InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States

SHANGHAI, March 17, 2020 /PRNewswire/ -- InxMed (Shanghai) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced today that the company has dosed first patient in its Phase Ib clinical ...

2020-03-17 09:05 2991

Samsung Biologics expands presence in Greater China Region with CDO partnership for Alzheimer's candidate

SONGDO, South Korea, March 16, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) entered into a contract development and manufacturing agreement with APRINOIA Therapeutics to develop an anti-tau monoclonal antibody candidate to treat primary and secondary tauopathies, including Progressive Supr...

2020-03-17 08:04 1451

EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV™ Nanocells to Mount Dual Assault on Cancer Cells

EDV™ Technology Stimulates Both Innate and Adaptive Immune Response and Confers Long-Term Survival Research Paves Way for Treatment of Drug-Resistant, End-Stage Cancers NEW YORK and SYDNEY, March 17, 2020 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its ...

2020-03-17 00:35 2039

China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

TAIZHOU, China, March 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC ) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales o...

2020-03-16 21:16 5064

Yuyu Pharma, Medicine Donation to Korean Red Cross

SEOUL, South Korea, March 16, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu) (KRX 000220) has donated vitamins, anti-fever medicine, and anti-allergy medication to help the people in Daegu and Gyeongbuk regions, which have both been hit hard by the Coronavirus. These include the vitamin...

2020-03-16 08:00 2953

Merck and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study

Not intended for US-, Canada- and UK-based media  DARMSTADT, Germany and NEW YORK, March 13, 2020 /PRNewswire/ -- Merck and Pfizer Inc. (NYSE: PFE) today announced an update from the Phase III JAVELIN Head and Neck 100 study evaluating avelumab in addition to chemoradiotherapy (CRT) versus stand...

2020-03-13 20:00 8070

Embracing the Age of Innovation with Chinese Pharmaceutical Practitioners, CPhI China Returns with its 20th Edition in 2020

SHANGHAI, March 13, 2020 /PRNewswire/ -- China's pharmaceutical industry is rapidly switching from the "quantity increase" to the "quality improvement", developing from a "generic drug power" to an "innovative drug power". CPhI China, a participant and witness of this historic stage, has forged a...

2020-03-13 09:00 3488

China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019

BEIJING, March 12, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its financial results for the fourth quarter and fiscal year of 2019. Fourt...

2020-03-13 05:00 10299

International Psoriasis Council Statement On The Coronavirus (COVID-19) Outbreak

ST. LOUIS, March 13, 2020 /PRNewswire/ -- The rapid spread of the coronavirus (COVID-19) is a serious public health concern. It remains unknown to what extent the coronavirus impacts psoriasis and the treatment of psoriasis.  The International Psoriasis Council (IPC) advises physicians to be aler...

2020-03-13 03:59 2262

INOVIO Receives New $5 Million Grant to Accelerate Scale Up of Smart Delivery Device for Its COVID-19 Vaccine

PLYMOUTH MEETING, Pennsylvania, March 12, 2020 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new$5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the ...

2020-03-12 20:00 3264

Bactiguard Launches Product That Protects Against Coronavirus

STOCKHOLM, March 12, 2020 /PRNewswire/ -- Bactiguard launches HYDROCYN aqua®, a water-based product that has been proven to have a powerful effect on killing previous variants of coronavirus within 15-30 seconds. Previous experience shows that the proven effect can be transferred to new variants ...

2020-03-12 15:49 2748

Progress of the Small Sample Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia

HANGZHOU, China and SHAOXING, China, March 10, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the progress of the small sample clinical trial of Ganovo® and Ritonavir combination therapy on Novel Coronavirus Pneumonia. One of the treatment groups in this study is the ...

2020-03-10 17:30 3972

Pebble Labs and Virbac Announce the Signing of a Comprehensive Commercial Agreement for Aquaculture Disease Prevention

Companies will work to bring RNA-based technologies to global large-scale aquaculture, and focus on a solution for White Spot Syndrome Virus, a disease that can cause 50% crop loss LOS ALAMOS, New Mexico and CARROS, France, March 10, 2020 /PRNewswire/ --  Pebble LabsUSA Inc., a biotechnology comp...

2020-03-09 23:41 3422
1 ... 301302303304305306307 ... 313

Week's Top Stories